Lucid Group Inc
F:CH2A
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Lucid Group Inc
F:CH2A
|
US |
|
Teva Pharmaceutical Industries Ltd
TASE:TEVA
|
IL |
|
Thales SA
F:CSF0
|
FR |
|
B
|
Beyond Securities PCL
SET:BYD
|
TH |
|
U
|
Unum Group
XMUN:UUM
|
US |
|
T
|
Titan Machinery Inc
XBER:3TY
|
US |
|
A
|
Amgen Inc
XMUN:AMG
|
US |
|
A
|
AI Energy PCL
SET:AIE
|
TH |
|
Almonty Industries Inc
F:ALI1
|
CA |
Wall St Price Targets
CH2A Price Targets Summary
Lucid Group Inc
According to Wall Street analysts, the average 1-year price target for
CH2A is 22.92 EUR with a low forecast of 12.71 EUR and a high forecast of 44.92 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CH2A's stock price target?
Price Target
22.92
EUR
According to Wall Street analysts, the average 1-year price target for
CH2A is 22.92 EUR with a low forecast of 12.71 EUR and a high forecast of 44.92 EUR.
What is the Revenue forecast for Lucid Group Inc?
Projected CAGR
86%
Over the last 5 years, the compound annual growth rate for Revenue has been 221%. The projected CAGR for the next 3 years is 86%.